Vir Biotechnology's total assets for Q2 2025 were $1.19B, a decrease of -8.81% from the previous quarter. VIR total liabilities were $245.06M for the fiscal quarter, a -7.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.